Bayoumi Nader H
J Pediatr Ophthalmol Strabismus. 2018 May 1;55(3):164-170. doi: 10.3928/01913913-20171129-02. Epub 2018 Jan 31.
To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma.
This was a prospective study conducted in the Department of Ophthalmology at Alexandria Main University Hospital, Alexandria, Egypt, on 75 eyes with primary congenital glaucoma that underwent combined trabeculotomy-trabeculectomy with intraoperative mitomycin C application for 1 minute (MMC 1) or 2 minutes (MMC 2) and were followed up for 24 months. Success rates were studied and complications noted. Success was defined by a composite primary end point of an intraocular pressure (IOP) of less than 16 mm Hg under general anesthesia, without any IOP-lowering medications and with no hypotony-related complications and/or lack of IOP-related progression of the disease as evidenced by worsening of the ocular biometric characteristics.
The mean age of the study participants was 6.7 ± 4.1 months (range: 2 to 16 months; median: 6 months) in the MMC 1 group (35 eyes) and 7.7 ± 5.7 months (range: 1 to 32 months; median: 6.5 months) in the MMC 2 group (40 eyes). The initial surgery was successful in 32 (91.5%) and 31 (77.5%) eyes in the MMC 1 and MMC 2 groups, respectively. The mean IOP was 18.4 ± 5.1 and 18.1 ± 6.1 mm Hg preoperatively and 5.5 ± 3.5 and 4.8 ± 2.8 mm Hg at the end of follow-up in the MMC 1 and MMC 2 groups, respectively. There was no statistically significant difference in the clinical parameters between the two groups. Complications included cataracts in each group and hypotony optic disc edema in 3 eyes (7.5%) in the MMC 2 group.
Both mitomycin C application durations were effective in combined trabeculotomy-trabeculectomy with mitomycin C for primary congenital glaucoma. The longer duration was not advantageous in disease control and there were no significant differences in complications. [J Pediatr Ophthalmol Strabismus. 2018;55(3):164-170.].
比较丝裂霉素C两种暴露时间在原发性先天性青光眼联合房角切开和小梁切除术中的效果。
这是一项前瞻性研究,在埃及亚历山大市亚历山大主大学医院眼科进行,对75只原发性先天性青光眼患眼进行小梁切开术联合小梁切除术,并术中应用丝裂霉素C 1分钟(MMC 1组)或2分钟(MMC 2组),随访24个月。研究成功率并记录并发症。成功定义为复合主要终点,即全身麻醉下眼压(IOP)低于16 mmHg,无需任何降眼压药物,无低眼压相关并发症和/或无IOP相关疾病进展,如眼生物测量特征恶化所示。
MMC 1组(35只眼)研究参与者的平均年龄为6.7±4.1个月(范围:2至16个月;中位数:6个月),MMC 2组(40只眼)为7.7±5.7个月(范围:1至32个月;中位数:6.5个月)。MMC 1组和MMC 2组分别有32只眼(91.5%)和31只眼(77.5%)初次手术成功。MMC 1组和MMC 2组术前平均IOP分别为18.4±5.1和18.1±6.1 mmHg,随访结束时分别为5.5±3.5和4.8±2.8 mmHg。两组临床参数无统计学显著差异。并发症包括每组均有白内障,MMC 2组有3只眼(7.5%)出现低眼压性视盘水肿。
两种丝裂霉素C应用时间在原发性先天性青光眼小梁切开术联合小梁切除术并应用丝裂霉素C中均有效。较长时间在疾病控制方面并无优势,并发症方面也无显著差异。[《小儿眼科与斜视杂志》。2018;55(3):164 - 170。]